Mehran Khorsandi, M.D.: Chairman, CEO, Co-Founder
Henry Bourang: President, COO, Co-Founder
Richard Ferrari: Director
Mr. Ferrari is a Co-Founder of De Novo Ventures which has $650 million under management and which
is one of the premier firms dedicated to medical devices and biotechnology. Mr Ferrari has extensive
experience in the medical devices sector, including being CEO of Cardiovascular Imaging Systems (the
first and leading developer of ultrasound imaging catheters acquired by Boston Scientific) and
CardioThoracic Systems (the market leader in disposable instruments and systems for performing
minimally invasive beating heart bypass surgery acquired by Guidant). Mr Ferrari also co-founded the
Medical Technology Group which spun-out Integrated Vascular Systems, acquired by Abbott Vascular
and Ensure, acquired by J&J.
Mr. Ferrari also serves as a faculty member of the Stanford Biodesign Emerging Entrepreneurs Forum,
as well as a board member for the Stanford | Coulter Foundation for Translational Medicine. Mr Ferrari
is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the
Entrepreneur of the Year Award.
Rich holds a BS degree from Ashland University and an MBA from the University of South Florida.